Rhinovirus colocalizes with CD68- and CD11b-positive macrophages following experimental infection in humans - 02/09/13

| This work was supported by National Institutes of Health grants HL081420 (to M.B.H.) and U19 AI070503 (to J.E.G.). |
|
| Disclosure of potential conflict of interest: J. K. Bentley and M. B. Dzaman have been supported by one or more grants from the National Institutes of Health (NIH) (HL081420). J. E. Gern has received consultancy fees from GlaxoSmithKline, Biota, Centocor, Boehringer Ingelheim, MedImmune, Theraclone, and Merck and has received one or more grants from Merck, AstraZeneca, and GlaxoSmithKline. M. B. Hershenson has been supported by one or more grants from the NIH and has consultancy arrangements with Boehringer Ingelheim, Gilead, and Almirall. U. S. Sajjan has received one or more grants from or has one or more grants pending with the NIH. The rest of the authors declare that they have no relevant conflicts of interest. |
Vol 132 - N° 3
P. 758 - septembre 2013 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
